Pharma Mar S.A. (PHM) — Strategic Asset Allocation Index
Pharma Mar S.A. (PHM) has a Strategic Asset Allocation Index of 18.6% as of June 2023. Strategic assets (PP&E of €39.19 Million plus long-term investments of €-) total €39.19 Million, measured against net assets of €210.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Pharma Mar S.A. Strategic Asset Allocation Index (2013–2022)
This chart shows how Pharma Mar S.A.'s Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 18.6%, representing strategic assets of €39.19 Million against net assets of €210.30 Million EUR. Explore PHM operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Pharma Mar S.A. (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharma Mar S.A. from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PHM market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 15.6% | €34.72 Million | €34.72 Million | €- | €222.96 Million | ▲ +0.5 pp |
| 2021 | 15.1% | €26.90 Million | €26.90 Million | €- | €177.92 Million | ▼ -9.0 pp |
| 2020 | 24.1% | €24.75 Million | €24.75 Million | €- | €102.72 Million | ▼ -333.1 pp |
| 2019 | 357.2% | €26.63 Million | €25.60 Million | €1.03 Million | €7.46 Million | ▲ +206.3 pp |
| 2018 | 150.8% | €26.36 Million | €25.47 Million | €884.00K | €17.47 Million | ▲ +13.3 pp |
| 2017 | 137.5% | €31.61 Million | €30.63 Million | €977.00K | €22.98 Million | ▲ +75.5 pp |
| 2016 | 62.0% | €30.09 Million | €28.95 Million | €1.14 Million | €48.49 Million | ▲ +19.1 pp |
| 2015 | 42.9% | €31.34 Million | €30.27 Million | €1.07 Million | €73.04 Million | ▼ -4.5 pp |
| 2014 | 47.5% | €28.50 Million | €27.43 Million | €1.07 Million | €60.07 Million | ▲ +5.8 pp |
| 2013 | 41.6% | €20.58 Million | €19.57 Million | €1.01 Million | €49.44 Million | — |